Ultrafast and high-throughput mass spectrometric assay for therapeutic drug monitoring of antiretroviral drugs in pediatric HIV-1 infection applying dried blood spots

Kaletra® (Abott Laboratories) is a co-formulated medication used in the treatment of HIV-1-infected children, and it contains the two antiretroviral protease inhibitor drugs lopinavir and ritonavir. We validated two new ultrafast and high-throughput mass spectrometric assays to be used for therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Meesters, Roland J. W., van Kampen, Jeroen J. A., Reedijk, Mariska L., Scheuer, Rachel D., Dekker, Lennard J. M., Burger, David M., Hartwig, Nico G., Osterhaus, Albert D. M. E., Luider, Theo M., Gruters, Rob A.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919689/
https://www.ncbi.nlm.nih.gov/pubmed/20632164
http://dx.doi.org/10.1007/s00216-010-3952-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919689/
https://www.ncbi.nlm.nih.gov/pubmed/20632164
http://dx.doi.org/10.1007/s00216-010-3952-9

Ejemplares similares